MAJEM, M.; ÁLVAREZ, R.; ORTEGA, A. L.; RUIZ DE ALDA, L.; GORDO, R.; GARCÍA, J. F.; IVANOVA-MARKOVA, Y.; GONZÁLEZ-DOMÍNGUEZ, A.; SÁNCHEZ SAN CRISTÓBAL, R.; ROJO, F. Cost-benefit analysis of ALK diagnosis vs. non-diagnosis in patients with advanced non–small cell lung cancer in Spain. Global and Regional Health Technology Assessment, [S. l.], v. 9, n. 1, p. 82–90, 2022. DOI: 10.33393/grhta.2022.2449. Disponível em: https://journals.aboutscience.eu/index.php/grhta/article/view/2449. Acesso em: 3 jul. 2024.